2-(((2-Chlorophenyl)thio)methyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole

Catalog No. :
ACEMSZ638
CAS No. :
869357-04-0
Molecular Formula :
C18H17ClN2O4S
Molecular Weight :
392.86

IUPAC Name:2-(((2-chlorophenyl)thio)methyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole

2-(((2-Chlorophenyl)thio)methyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$221.00Login to see priceIn stockInquiry
250mg98%$372.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(((2-Chlorophenyl)thio)methyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole
IUPAC Name2-(((2-chlorophenyl)thio)methyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole
Molecular FormulaC18H17ClN2O4S
Molecular Weight392.86
SMILESCOC1=CC(C2=NN=C(CSC3=CC=CC=C3Cl)O2)=CC(OC)=C1OC
InChI KeySXAVIFMBBNGEQR-UHFFFAOYSA-N
Synonym1,3,4-Oxadiazole, 2-[[(2-chlorophenyl)thio]methyl]-5-(3,4,5-trimethoxyphenyl)-;2-(((2-Chlorophenyl)thio)methyl)-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole;WAY-325695
CAS No.869357-04-0
PubChem CID7950375

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACEMSZ638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEMSZ638 route product structure diagram
    ACEMSZ638869357-04-0 In Stock
Inquiry

2. ACEMSZ638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEMSZ638 route product structure diagram
    ACEMSZ638869357-04-0 In Stock
Inquiry

Comments (0)